Related Experiment Video
Updated: Dec 23, 2025

05:41
Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis
Published on: February 9, 2024
963
Distinguishing Recurrent Thyroid Cancer from Residual Nonmalignant Thyroid Tissue Using Multiphasic Multidetector CT
J M Debnam1, N Guha-Thakurta2, J Sun3
1From the Departments of Diagnostic Radiology, Section of Neuroradiology (J.M.D., N.G.-T., N.M.B., D.S.) Matthew.Debnam@mdanderson.org.
AJNR. American Journal of Neuroradiology
|April 25, 2020
Summary
Multiphasic multidetector computed tomography (4D-MDCT) can accurately differentiate recurrent thyroid cancer from residual nonmalignant thyroid tissue after thyroidectomy. Precontrast imaging offers the most diagnostic information for distinguishing benign from malignant thyroid tissue.
Area of Science:
- Radiology
- Oncology
- Endocrinology
Background:
- Incomplete thyroidectomy can lead to residual thyroid tissue, complicating post-surgical imaging surveillance.
- Distinguishing residual nonmalignant thyroid from recurrent thyroid carcinoma is crucial for patient management.
Purpose of the Study:
- To evaluate the efficacy of multiphasic multidetector computed tomography (4D-MDCT) in differentiating residual nonmalignant thyroid tissue from recurrent thyroid carcinoma.
- To determine the optimal imaging phase for this differentiation.
Main Methods:
- Retrospective analysis of 4D-MDCT scans in patients who underwent thyroidectomy.
- Comparison of Hounsfield unit values in precontrast, arterial, venous, and delayed phases for recurrent cancer, normal thyroid, and diseased thyroid (thyroiditis/multinodular).
- Statistical analysis using ANOVA, logistic regression, and ROC analysis to assess differentiation performance.
Main Results:
- All tissue types exhibited similar enhancement patterns (wash-in/washout).
- Significant differences in Hounsfield unit density were observed among the three groups across all phases (P < .001).
- The precontrast phase demonstrated the highest accuracy (AUC = 0.983) in differentiating recurrent cancer from benign tissue, followed by the arterial phase.
Conclusions:
- 4D-MDCT effectively distinguishes recurrent thyroid carcinoma from residual nonmalignant thyroid tissue with high accuracy.
- Precontrast imaging provides the most valuable information for differentiation, followed by the arterial phase.
- Clinical protocols should incorporate a precontrast phase for optimal diagnostic performance.

